Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-11060165 · Data updated 2026-11-12
This study is looking at how well different vaccines and prevention methods work against HIV using nonhuman primates, and it's designed to help researchers find effective ways to protect people from the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $118,801 |
| NIH project number | 75N93020D00008-P00005-759302000002-1 |
| Project ID | NIH-11060165 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccine programs may not receive direct benefits from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines and prevention strategies for HIV. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for conducting preclinical studies, allowing researchers to assess immune responses and vaccine efficacy. By maintaining a breeding colony and ensuring proper housing and care for these primates, the program supports various stages of AIDS vaccine research, aiming to identify effective vaccines that can prevent or control HIV infection.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly impacting public health.
How similar studies have gone: Previous research using nonhuman primates has shown promise in evaluating HIV vaccines, indicating that this approach has a history of success.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.